dimethyl sulfone has been researched along with Breast Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, L; Becherini, C; Bonomo, P; Ciccone, LP; Desideri, I; Francolini, G; Greto, D; Livi, L; Lucidi, S; Meattini, I; Morelli, I; Salvestrini, V; Scotti, V; Terziani, F; Valzano, M; Visani, L | 1 |
| Bannon, M; Caron, JM; O'Donovan, L; Rosshirt, L | 1 |
| Bannon, M; Caron, JM; Deckers, PJ; Monteagudo, L; Sanders, M | 1 |
| Chang, SH; Cho, BW; Darvin, P; Hwang, TS; Joung, YH; Kang, DY; Kim, DN; Kim, HS; Kim, SY; Kim, WS; Lee, HK; Park, JH; Park, KD; S P, N; Yang, YM; Yoo, YB | 1 |
| Byun, HJ; Darvin, P; Joung, YH; Kang, DY; Sp, N; Yang, YM; Yoo, YB | 1 |
| Cho, BW; Darvin, P; Do Park, K; Hong, DY; Hwang, TS; Joung, YH; Kim, SY; Lee, HK; Lim, EJ; Moon, ES; Na, YM; Park, JH; Park, T; Yang, YM; Ye, SK | 1 |
1 trial(s) available for dimethyl sulfone and Breast Neoplasms
| Article | Year |
|---|---|
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833).
Topics: Aromatase Inhibitors; Arthralgia; Boswellia; Breast Neoplasms; Bromelains; Dietary Supplements; Dimethyl Sulfoxide; Female; Humans; Immunologic Factors; Prospective Studies; Sulfones | 2022 |
5 other study(ies) available for dimethyl sulfone and Breast Neoplasms
| Article | Year |
|---|---|
Methyl sulfone manifests anticancer activity in a metastatic murine breast cancer cell line and in human breast cancer tissue--part I: murine 4T1 (66cl-4) cell line.
Topics: Actins; Animals; Antineoplastic Agents; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dimethyl Sulfoxide; Epithelial-Mesenchymal Transition; Extracellular Matrix; Female; Humans; Mice; Sulfones; Wound Healing | 2013 |
Methyl sulfone manifests anticancer activity in a metastatic murine breast cancer cell line and in human breast cancer tissue--part 2: human breast cancer tissue.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Movement; Cells, Cultured; Dimethyl Sulfoxide; Female; Humans; Hyaluronan Receptors; Mice; Octamer Transcription Factor-3; Sulfones; Wound Healing | 2013 |
The combination of methylsulfonylmethane and tamoxifen inhibits the Jak2/STAT5b pathway and synergistically inhibits tumor growth and metastasis in ER-positive breast cancer xenografts.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Estrogen Receptor alpha; Female; Humans; Janus Kinase 2; Neoplasm Metastasis; Receptors, Somatomedin; Signal Transduction; STAT5 Transcription Factor; Sulfones; Tamoxifen; Xenograft Model Antitumor Assays | 2015 |
Methylsulfonylmethane inhibits HER2 expression through STAT5b in breast cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Promoter Regions, Genetic; Receptor, ErbB-2; Signal Transduction; STAT5 Transcription Factor; Sulfones | 2016 |
Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Chlorocebus aethiops; COS Cells; Dimethyl Sulfoxide; Down-Regulation; Female; Gene Expression; Humans; Inhibitory Concentration 50; Mice; Promoter Regions, Genetic; Protein Binding; Receptor, IGF Type 1; STAT3 Transcription Factor; STAT5 Transcription Factor; Sulfones; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |